Connect with us

Hi, what are you looking for?


Elevance Health revenue growth hurt by a $1.8B unrealized loss

Elevance Health (NYSE: ELV), the giant insurance company, had a strong performance in the first quarter as the number of insurance enrolments increased. Its revenue and earnings per share (EPS) were better than estimates.

Elevance said that its revenue jumped to $41.9 billion in the first quarter a 10.6% increase from what it made in the same quarter last year. The company attributed this growth to higher enrolments as the number of customers jumped by more than 1.3 million to 48.1 million.

Elevance also attributed this performance to growth in Medicaid, Medicare Advantage, and Obamacare plan members. Meanwhile, the company said that its operating cash flow was about $6.5 billion, helped by premium receipts from CMS.

Elevance Health has continued buying back its stock. In Q1, it repurchased shares worth more than $622 million. It now has over $6.3 billion of the recent share repurchase plan training. In all, the company’s outstanding shares have fallen from 264 million in 2018 to 242 million. In the same period, its earnings per share (EPS) has jumped from $14.19 to $24.8. The CEO said:

““Through our diverse and expanding offering of products and solutions, and our alignment with high-performing, value-based care providers, we continue to meet the needs of consumers, customers and the communities we serve.”

Still, like other banks and insurance companies, Elevance Health is facing challenges as interest rates rise. The firm disclosed that its net unrealized loss in its investment portfolio rose to $1.8 billion. Elevance stock price dropped by over 1.8% in the premarket session.

The post Elevance Health revenue growth hurt by a $1.8B unrealized loss appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Latest News

    Rep. Jennifer Wexton (D-Va.) announced on Tuesday that she has been diagnosed with Parkinson’s Disease. “If there’s one thing that Democrats and Republicans can...

    Latest News

    After Dianne Feinstein announced she’d contracted the shingles in early March, her staff said she planned to return to the Senate within a matter...


    A U.S. District Court judge has ruled that Elizabeth Holmes, founder and CEO of the disgraced blood-testing company Theranos, cannot remain free on bail...

    Latest News

    SEOUL, South Korea — When a group of American lawmakers arrived in South Korea for meetings with government and military officials, President Yoon Suk-yeol...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2022 All Rights Reserved.